Leukemias are malignancies of the bone marrow. There are several different types of leukemia. Optimal treatment for leukemia depends on the exact type of leukemia as well as other factors such as patient age, the presence of DNA (cytogenetic) abnormalities within the leukemia cells, and previous treatment. Making treatment recommendations for patients with leukemia can be quite complex and is best done by physicians with special expertise in this area, such as the physicians of the Leukemia Team at the University of Nebraska Medical Center (UNMC). The Leukemia Team physicians dedicate their practice to the treatment of leukemia only. Through the UNMC Leukemia Team, patients have access to the latest research findings and innovative clinical trials. Diseases that are commonly treated by the Leukemia Team at UNMC include Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML), and Myelodysplastic Syndrome (MDS). In addition, the UNMC Leukemia Team commonly treats patients with bone marrow failure problems, such as Aplastic Anemia, Large Granular Lymphocyte Leukemia and Pure Red Cell Aplasia as well as myeloproliferative neoplasms.
The UNMC Leukemia Team provides consultations and second opinions as well as state-of-the-art treatment. Treatment may be a standard treatment or participation in a clinical research trial. Furthermore, the UNMC Leukemia Team offers a full spectrum of bone marrow and stem cell transplantation options, including mini transplants, unrelated donor transplants and cord blood transplants. The UNMC Leukemia Team works together closely with your referring oncologist or primary care provider to customize your treatment according to your needs and preferences.
To refer a patient or schedule an appointment you may call our general appointment line at 402-559-5600 or you can call one of the case manager: Diane Hill-Polerecky 402-559-4997.